|
Type of cells | Immune players influenced at injury milieu | Effects on recovery | Citations |
|
Neural stem cells (NSCs) | FGF2 HGF CD133+/CD34−/CD45− Neurogenin-2 GSI | Facilitatory Facilitatory Facilitatory Facilitatory Tumor inhibition | [55] [61] [62] [67] [72] |
|
Schwann cells (SCs) | p75 GFAP S100 L1 N-CAM NGF BDNF GDNF CNTF IL-10 Fibronectin Laminin | Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory | [3, 74] [3, 74] [3, 74] [3, 74] [3, 74] [78–81] [78–81] [78–81] [78–81] [86–88] [74] [74] |
|
Olfactory ensheathing cells (OECs) | p75 GFAP S100 L1 N-CAM Fibronectin Laminin | Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory | [3, 74] [3, 74] [3, 74] [3, 74] [3, 74] [74] [74] |
|
Ependymal cells | EGF FGF2 | Facilitatory Facilitatory | [107] [107] |
|
Human central nervous system stem cell (HuCNS-SC) | Further studies needed | Facilitatory | [109] |
|
Erythropoietin-releasing neural precursors cells (Er-NPCs) | Macrophages rhEPO 5-TH GAP43 BDNF NGF β-Tubulin III MAP-2 | Inhibitory Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory | [31, 112] [117] [31, 116, 117] [31, 118–120] [116, 122, 123] [116, 122, 123] [31] [31] |
|
Mesenchymal stem cells (MSCs) | 5-HT GAP43 BDNF VEGF FGF2 MAP-2 GABA-A BNP TGF-β | Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory Facilitatory | [137] [128, 147] [4, 148] [4, 148] [4, 148] [4, 151] [4, 151] [4, 152, 153] [4, 161, 162] |
|
Induced pluripotent stem cells (iPSCs) | GSI HSVtk GCV | Tumor inhibition Tumor inhibition Tumor inhibition | [1] [1] [1] |
|
Umbilical cord blood cells (UCBCs) | CD34+/CD45− CD133+ | Facilitatory Facilitatory | [3] [3] |
|